---
figid: PMC4440819__pone.0127888.g007
figlink: /pmc/articles/PMC4440819/figure/pone.0127888.g007/
number: F7
caption: (A) TGF-β1-induced Smad2/3 signaling is essential for EMT from RLE cells
  to myofibroblasts expressing αSMA, collagen 1, and fibronectin. TGF-β1-induced Ras
  activity is weak, and intrinsic DA-Raf is sufficient to suppress the ERK pathway
  by binding to activated Ras. (B) FGF2 stimulation (as well as FGF1 or HGF stimulation)
  or overexpression of the constitutively active Ras, Raf, or MEK intensifies the
  activity of the Ras—ERK pathway activated by TGF-β1. Intrinsic DA-Raf is not sufficient
  to overcome the strong Ras—ERK pathway activity. Activated ERK might interfere with
  the nuclear translocation of Smad2/3, which is required to induce EMT.
pmcid: PMC4440819
papertitle: DA-Raf-Mediated Suppression of the Ras—ERK Pathway Is Essential for TGF-β1-Induced
  Epithelial—Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
reftext: Haruko Watanabe-Takano, et al. PLoS One. 2015;10(5):e0127888.
pmc_ranked_result_index: '55655'
pathway_score: 0.9454297
filename: pone.0127888.g007.jpg
figtitle: DA-Raf-Mediated Suppression of the Ras—ERK Pathway Is Essential for TGFB1-Induced
  Epithelial—Mesenchymal Transition in Alveolar Epithelial Type 2 Cells
year: '2015'
organisms:
- Homo sapiens
ndex: f5daa82e-deeb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4440819__pone.0127888.g007.html
  '@type': Dataset
  description: (A) TGF-β1-induced Smad2/3 signaling is essential for EMT from RLE
    cells to myofibroblasts expressing αSMA, collagen 1, and fibronectin. TGF-β1-induced
    Ras activity is weak, and intrinsic DA-Raf is sufficient to suppress the ERK pathway
    by binding to activated Ras. (B) FGF2 stimulation (as well as FGF1 or HGF stimulation)
    or overexpression of the constitutively active Ras, Raf, or MEK intensifies the
    activity of the Ras—ERK pathway activated by TGF-β1. Intrinsic DA-Raf is not sufficient
    to overcome the strong Ras—ERK pathway activity. Activated ERK might interfere
    with the nuclear translocation of Smad2/3, which is required to induce EMT.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACTA2
  - MAPK3
  - MAP2K2
  - ARAF
  - RAF1
  - BRAF
  - HRAS
  - MAPK1
  - KRAS
  - COL1A2
  - COL1A1
  - MAP2K1
  - FGFR1
  - FGF2
  - TGFB1
  - FN1
  - FGFR4
  - NRAS
  - SMAD3
  - FGFR2
  - SMAD2
  - FGFRL1
  - FGFR3
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: Acta2,Col1,Fn1
  symbol: ACTA2
  source: hgnc_symbol
  hgnc_symbol: ACTA2
  entrez: '59'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Acta2,Col1,Fn1
  symbol: COL1
  source: bioentities_symbol
  hgnc_symbol: COL1A2
  entrez: '1278'
- word: Acta2,Col1,Fn1
  symbol: COL1
  source: bioentities_symbol
  hgnc_symbol: COL1A1
  entrez: '1277'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGF2
  symbol: FGF2
  source: hgnc_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: TGF-B1
  symbol: TGFB1
  source: hgnc_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: Acta2,Col1,Fn1
  symbol: FN1
  source: hgnc_symbol
  hgnc_symbol: FN1
  entrez: '2335'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4440819__F7
redirect_from: /figures/PMC4440819__F7
figtype: Figure
---
